7 claves para diferenciar los productos engaño de los medicamentos según Cofepris

Manipulating the Prescription Drug Market: Spiking Prices, Inducing Demand, and Costs to the Public

The Impact of Health Disparities in Patient Safety

Revisiting the Frequency and Antimicrobial Resistance Patterns of Bacteria Implicated in Community Urinary Tract Infections

Fraud and Corruption in Healthcare

UK veterinary professionals' perceptions and experiences of adverse drug reaction reporting

A data-driven pipeline to extract potential adverse drug reactions through prescription, procedures and medical diagnoses analysis: application to a cohort study of 2,010 patients taking hydroxychloroquine with an 11-year follow-up

DEA: Around 40% of illegal drugs sold may be counterfeit, having a high dose of fentanyl

 

Study Shows Counterfeit Drug Concerns

El futuro de la elaboración de medicamentos: comentarios al proyecto de modificación del RD175/2001

Safety of Antibiotics in Hospitalized Children in Romania: A Prospective Observational Study

Convergence of Blockchain, IoMT, AI for Healthcare Platform Framework

Estudio observacional retrospectivo de eventos adversos asociados al tratamiento de COVID-19

Anticoagulación en el Paciente Geriátrico: Búsqueda Sistemática de la Literatura

IDF21-0195 Reported pregnancy outcomes with insulin glargine 300 U/mL: a post-marketing survey of pharmacovigilance data

Association between NMDAR antagonists, drug abuse and dependence: a disproportionality analysis from the WHO pharmacovigilance database

A questionnaire-based pharmacovigilance study of adverse events following immunization between Covishield and Covaxin at a tertiary care hospital

Hefame subraya la seguridad de la venta de fármacos veterinarios en las oficinas de farmacia

Así es como opera el mercado negro de medicinas anticovid

Expertos reclaman que el mercado de vacunas de la alergia se "armonice" para asegurar su "seguridad, calidad y eficacia"

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

Impacto de la pandemia COVID-19 en los sistemas de notificación de incidentes de seguridad del paciente y errores de medicaciónImpact of the COVID-19 pandemic on patient safety incident and medication error reporting systems

Ambulatory Medication Safety in Primary Care: A Systematic Review

I (Don’t) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines

Ensuring Patient Safety Through Elemental Impurity Analysis

Counterfeit drugs are being sold on social media

 

The FDA is busy busting up drug counterfeiting rings—but is it doing enough to protect patients?

FDA agrees to reconsider safety of BPA in food packaging

Adopt Strategies to Manage Look-Alike and/or Sound-Alike Medication Name Mix-Ups

La AEMPS presenta la Memoria 2021, un año protagonizado por la llegada de las vacunas frente a la COVID-19

Factors Explaining Consumer's Attitudes Towards Buying Counterfeit Drugs in North Cameroon

Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center

Rates and Factors Associated With Serious Outcomes of Patient Safety Incidents in Malaysia: An Observational Study

FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply

Fake news and the seven sins of capital: a metaphorical analysis of vices in the context of the COVID-19 pandemic

Factors influencing adoption of blockchain technology in the pharmaceutical supply chain for prevention of counterfeit drugs: Environmental Perspective

Malaria: Existence Perpetuated by a Counterfeit Drug Industry

Invima alerta sobre potenciador sexual fraudulento que está siendo comercializado en el país

COMUNICACIÓN DE RIESGO NO. 01/22: ACTUALIZACIÓN DE LA INFORMACIÓN DE SEGURIDAD DE TRAMADOL